Motley Fool Asset Management LLC Purchases 3,971 Shares of Veeva Systems Inc. $VEEV

Motley Fool Asset Management LLC boosted its position in Veeva Systems Inc. (NYSE:VEEV) by 35.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,285 shares of the technology company’s stock after purchasing an additional 3,971 shares during the quarter. Motley Fool Asset Management LLC’s holdings in Veeva Systems were worth $3,412,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in VEEV. Sivia Capital Partners LLC boosted its stake in Veeva Systems by 225.9% in the 2nd quarter. Sivia Capital Partners LLC now owns 3,122 shares of the technology company’s stock valued at $899,000 after purchasing an additional 2,164 shares during the period. Bank of Nova Scotia raised its holdings in shares of Veeva Systems by 44.5% during the 2nd quarter. Bank of Nova Scotia now owns 5,866 shares of the technology company’s stock worth $1,689,000 after buying an additional 1,806 shares in the last quarter. NewEdge Advisors LLC raised its holdings in shares of Veeva Systems by 34.6% during the 2nd quarter. NewEdge Advisors LLC now owns 8,832 shares of the technology company’s stock worth $2,543,000 after buying an additional 2,272 shares in the last quarter. Treasurer of the State of North Carolina raised its holdings in shares of Veeva Systems by 2.2% during the 2nd quarter. Treasurer of the State of North Carolina now owns 68,950 shares of the technology company’s stock worth $19,856,000 after buying an additional 1,452 shares in the last quarter. Finally, Diversify Wealth Management LLC raised its holdings in shares of Veeva Systems by 5.3% during the 2nd quarter. Diversify Wealth Management LLC now owns 11,399 shares of the technology company’s stock worth $3,140,000 after buying an additional 575 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

VEEV has been the subject of a number of research analyst reports. Morgan Stanley boosted their price target on Veeva Systems from $205.00 to $215.00 and gave the stock an “equal weight” rating in a report on Thursday, March 5th. Wells Fargo & Company upped their target price on Veeva Systems from $317.00 to $320.00 and gave the stock an “overweight” rating in a report on Thursday, June 4th. UBS Group lowered their target price on Veeva Systems from $220.00 to $190.00 and set a “neutral” rating for the company in a report on Thursday, June 4th. Needham & Company LLC reaffirmed a “buy” rating and issued a $270.00 target price on shares of Veeva Systems in a report on Thursday, June 4th. Finally, Zacks Research cut Veeva Systems from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 14th. Eighteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $250.96.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: UCB is unifying global safety operations on Veeva Safety Suite, a sign of continued customer adoption for Veeva’s regulated-industry software platform. UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite
• Positive Sentiment: Analysts highlighted Veeva’s strong Q1, growing Vault CRM migrations, and AI expansion as reasons the stock may deserve a place in portfolios. Reasons to Add Veeva Systems Stock to Your Portfolio for Now
• Positive Sentiment: Management’s product push, including Falcon and Vault AI, is improving workflow automation across life sciences and supporting the long-term growth narrative. Veeva’s Falcon and Vault AI: When Could AI Become a Revenue Driver?
• Neutral Sentiment: Recent commentary from Veeva’s earnings call pointed to broad-based customer demand and stronger execution, but also said AI revenue is not expected to be a major contributor in fiscal 2027. The 5 Most Interesting Analyst Questions From Veeva Systems’s Q1 Earnings Call
• Negative Sentiment: Investors are also weighing concerns about saturation in the life sciences CRM market and the fact that AI monetization may take longer to show up in results. Reasons to Add Veeva Systems Stock to Your Portfolio for Now

Veeva Systems Stock Down 2.3%

Shares of VEEV opened at $163.82 on Thursday. Veeva Systems Inc. has a 12-month low of $148.05 and a 12-month high of $310.50. The business has a 50-day simple moving average of $165.61 and a two-hundred day simple moving average of $192.92. The stock has a market cap of $26.76 billion, a PE ratio of 29.20, a PEG ratio of 0.73 and a beta of 0.95.

Veeva Systems (NYSE:VEEV) last issued its earnings results on Wednesday, June 3rd. The technology company reported $2.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. The business had revenue of $882.95 million during the quarter, compared to analysts’ expectations of $857.73 million. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The business’s revenue for the quarter was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.97 EPS. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. On average, equities research analysts expect that Veeva Systems Inc. will post 6.55 EPS for the current year.

Insider Buying and Selling at Veeva Systems

In other news, Director Priscilla Hung sold 750 shares of the stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the completion of the sale, the director owned 3,253 shares of the company’s stock, valued at approximately $506,296.92. This represents a 18.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.60% of the company’s stock.

Veeva Systems Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.